Tegoyes 20MG Capsule is a combination medication primarily used in the treatment of certain types of cancer, particularly gastrointestinal cancers. This capsule contains three active ingredients: Gimeracil (4.35mg), Oteracil (11.8mg), and Tegafur (15mg). Gimeracil is known for its ability to inhibit the enzyme dihydropyrimidine dehydrogenase, which helps to enhance the effectiveness of Tegafur, a prodrug of 5-fluorouracil, a well-known chemotherapeutic agent. Oteracil serves to protect the gastrointestinal tract from the toxic effects of 5-fluorouracil. Together, these components work synergistically to improve the efficacy of cancer treatment while minimizing side effects. Tegoyes is typically prescribed as part of a comprehensive cancer treatment plan, and its formulation is designed to optimize therapeutic outcomes for patients undergoing chemotherapy.